ArticleCell2021

Identification of a therapeutic interfering particle-A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance.

Sonali Chaturvedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.